Advisornet Financial’s abrdn Life Sciences Investors HQL Stock Holding History

Advisornet Financial’s Portfolio HQL Stock Details HQL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-19	Closed	–	–	1783
2020 Q2	$0	Hold	19	–	–	﹤0.01%	1836
2020 Q1	$0	Hold	19	–	–	﹤0.01%	1844
2019 Q4	$0	Hold	19	–	–	﹤0.01%	1911
2019 Q3	$0	Hold	19	–	–	﹤0.01%	1897
2019 Q2	$0	Hold	19	–	–	﹤0.01%	1733
2019 Q1	$0	Hold	19	–	–	﹤0.01%	1611
2018 Q4	$0	Sell	19 -659	-97%	-$11.6K	﹤0.01%	1506
2018 Q3	$14K	Buy	678 +14	+2%	+$278	﹤0.01%	1037
2018 Q2	$12K	Buy	664 +13	+2%	+$245	﹤0.01%	1093
2018 Q1	$13K	Buy	651 +14	+2%	+$280	﹤0.01%	1026
2017 Q4	$13K	Buy	+637	New	+$12.8K	﹤0.01%	950

Other funds holding HQL

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

AAM

Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return

Matisse Capital Portland, Oregon $234M AUM 19.72% 1-Year Est. Return

FHA

Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Advisornet Financial's HQL Position: Q3 2020 in Review

Advisornet Financial sold out of abrdn Life Sciences Investors (HQL) in Q3 2020, closing a stake of 19 shares.

Advisornet Financial first reported a position in HQL in Q4 2017 and held it in 11 quarters. The position peaked at $14K in Q3 2018. 62 funds tracked by Wall St. Rank hold HQL as of Q3 2020.

Advisornet Financial reported no remaining abrdn Life Sciences Investors position as of Q3 2020 after selling out during the quarter.
Advisornet Financial sold 19 abrdn Life Sciences Investors shares in Q3 2020.
Advisornet Financial first reported a position in abrdn Life Sciences Investors in Q4 2017 and held it in 11 quarters.
Advisornet Financial's abrdn Life Sciences Investors position peaked at $14K in Q3 2018.
62 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q3 2020.

Based on Advisornet Financial's 13F filing for Q3 2020, filed 6 Nov 2020.